944903-70-2 Usage
Uses
Used in Pharmaceutical Industry:
(5-Phenylpyrimidin-2-yl)MethanaMine is used as an intermediate compound for the synthesis of various pharmaceuticals. Its unique chemical structure allows it to be a versatile building block in the development of new drugs, particularly those targeting nucleic acid-related pathways.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, (5-Phenylpyrimidin-2-yl)MethanaMine is used as a key component in the design and synthesis of novel therapeutic agents. Its properties make it valuable for exploring new drug candidates with potential applications in treating various diseases and conditions.
Used in Organic Synthesis:
(5-Phenylpyrimidin-2-yl)MethanaMine is utilized as a starting material in organic synthesis, enabling the creation of a wide range of organic compounds with diverse applications. Its unique structure allows for the development of new molecules with potential uses in various industries, including pharmaceuticals, agrochemicals, and materials science.
Used in Chemical Research and Development:
As a member of the pyrimidine class of compounds, (5-Phenylpyrimidin-2-yl)MethanaMine is employed in research and development efforts to better understand the properties and potential applications of this class of compounds. Its unique structure makes it an interesting subject for studying the interactions between different molecular groups and their effects on compound properties and reactivity.
Check Digit Verification of cas no
The CAS Registry Mumber 944903-70-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,4,9,0 and 3 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 944903-70:
(8*9)+(7*4)+(6*4)+(5*9)+(4*0)+(3*3)+(2*7)+(1*0)=192
192 % 10 = 2
So 944903-70-2 is a valid CAS Registry Number.
944903-70-2Relevant academic research and scientific papers
NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS
-
Page/Page column 48-49, (2011/04/14)
The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.
